<AD>

<WIRE> Solvar (ASX:SVR) Experiences Significant Drop Amid Gloomy Forecast

Shares in Australian finance firm, Solvar (ASX:SVR), plummeted as much as 27.2% to A$1.270, marking the company’s most severe single-day percentage drop since March 19.

This caused the stock to drop to its lowest value since April 28.

Solvar (ASX:SVR) disclosed that the company’s net profit after tax (NPAT) for FY24 would suffer from the annual cost of the rate hike cycle introduced by central banks.

The finance company anticipates an annualized NPAT for the fiscal year 2024 between A$24 million and A$30 million, significantly lower than this year’s NPAT of A$47.6 million.

However, the company also stated that it expects the EBITDA for FY24 to remain on par with the figures for FY23.

So far this year, the company’s stock has fallen by 4.6%, up until the last closing bell.

Solvar (ASX:SVR) is an Australian finance firm dealing with various financial services.

(Exchange rate: $1 = 1.5307 Australian dollars)


<WIRE> Downer EDI (ASX:DOW) Experiences Worst Day in 5 Months After Flagging Impairment Charges

Shares of Downer EDI (ASX:DOW) fell nearly 6% to A$4.17, reaching their lowest point since July 10.

This marked the company’s largest intraday percentage drop since February 27, cementing it as the largest percentage loser on the benchmarking ASX 200.

Downer EDI, the Australian contractor, foresees posting a statutory net loss after tax of about A$386 million.

The loss results from impairment charges.

Furthermore, Downer EDI signaled A$549.6 million in non-cash, pre-tax impairment charges for the fiscal year ending June 30, 2023.

Despite this setback, the company’s stock had seen a gain of 19.4% this year, prior to its most recent close.

Downer EDI is an Australian contractor known for its infrastructure and project management services.


<WIRE> Wall Street Slumps in Wake of Fitch Ratings Downgrade

Wall Street witnessed a significant slump as shares closed drastically lower due to a credit ratings downgrade from Fitch. The stock market had been profiting from steady gains in July, marking the fifth consecutive month of profit for the S&P 500 and the tech-focused Nasdaq Composite. The rise was propelled by better-than-expected earnings and promising expectations due to strong labor market and consumer spending statistics.

Despite the downgrade marking the second since 2011, when S&P nullified the country’s triple-A rating, financial analysts believe it won’t produce a long-term negative impact on U.S. financial assets, particularly the dollar, given the superior condition of the world’s largest economy as compared to 12 years ago.

History suggests this trend as the equities markets overlooked the last ratings downgrade in 2011, when the S&P 500 simply dropped by 7% but rebounded with a 20% rise from its lows, according to LPL Financial.

Other big players, such as Tesla, Nvidia, Meta Platforms and Apple, closed the day lower as the benchmark 10-year yield surged to its highest point in nearly nine months. Wall Street, a modern capitalist marketplace, is a real-time hub for cutting-edge market analysis brought to you by expert reporters.



<WIRE> Citi Raises Rating and Price Target of Orica (ASX:ORI)

Citi has increased Orica’s rating and price target.

The progression in mining activities across Australia in June has been deemed as a positive driver for Orica, prompting an upgrade to a ‘buy’ rating.

Citi believes that further mining activities within the Asia Pacific region should catalyze a near-term upswing, which will positively impact the demand for explosives.

Despite this, Citi does not anticipate a material rise in ammonia prices in the near future.

According to Refinitiv Data, of 13 analysts, nine recommend the stock as a ‘buy’ or higher, three suggest ‘hold’, and one recommends ‘sell’.

The median price target for them is A$17.40.

Orica’s shares have experienced a year-to-date increase of 3.1% as of the last closing.

Orica (ASX:ORI) is a leading provider of commercial explosives and innovative blasting systems to the mining, quarrying, oil and gas, and construction markets.


<WIRE> Aeris Resources (ASX:AIS) Reports Operating & Capital Costs Within or Below Revised Guidance for FY23

Aeris Resources has announced that its group operating and capital costs are projected to be within or below the revised guidance ranges for the full year FY23.

The announcement signifies the company’s financial resilience and adherence to its budgetary targets.

Aeris Resources is a mining and mineral exploration company primarily engaged in the production and sale of copper.


<WIRE> Risks Persist for EVT (ASX:EVT) Cinema Business Despite 'Barbenheimer' Fever, According to Citi

Analysts at Citi have downgraded their rating on Australian entertainment and leisure firm EVT (ASX:EVT) to neutral from buy, as they see increasing risks to its cinema business.

Despite the current excitement at the box office from the release of Oppenheimer and Barbie, the brokerage states that it hasn’t eased concerns arising from the ongoing writers' and actors' strike in Hollywood.

The strike is expected to have an adverse effect on box office results in CY24/25 if it continues.

While the brokerage is positive on EVT’s hotel business, they note that recent data point to slower growth.

Citi also reduced their price target for EVT to A$13.30 from A$17.11 and cut their FY23 core net profit outlook by 4.6% to A$72.7 million ($47.88 million), and by about 7% to A$98.3 million for FY24.

Among six analysts, two rate the stock as buy or higher, and four rate it as hold, with a median price target of A$13.50 per Refinitiv data.

As of the last close, EVT’s shares were trading 1.6% lower at A$11.98 and were down 4.2% so far this year.

EVT is an Australian based entertainment and leisure company.


<AD>


<WIRE> Aussie Gold Stocks Fall, Uncertainty Expected in Bullion Due to Hawkish Fed - Northern Star Resources (ASX:NST) & Newcrest Mining (ASX:NCM)

Australian gold stocks, such as Northern Star Resources (ASX:NST) and Newcrest Mining (ASX:NCM), have fallen as much as 1.9%.

The macroeconomic backdrop of gold is looking uncertain following the US Federal Reserve’s increase in rates by another 25bp while leaving the potential for further increase in September.

This observation was made by ANZ Research.

Atlanta Federal Reserve Bank President, Raphael Bostic, commented on Tuesday that he does not foresee any rate cuts until the second half of 2024.

ANZ further noted that investment demand remains lackluster as investors are waiting for the Federal Reserve to conclude its tightening cycle.

Both Northern Star Resources and Newcrest Mining have seen a decline in the range of 1.05% to 2.9%.

With shifting expectations surrounding the terminal rate, the upside may be capped in near term, according to an anonymous brokerage.

Despite the fall off, gold stocks have witnessed an increase of 15.6% YTD, as of last close, vs a 5.9% gain in the benchmark index.

Northern Star Resources is a leading gold production company, while Newcrest Mining is a prominent name in the production and exploration of gold and copper.


<WIRE> Codan (ASX:CDA) Reaches Nearly Two-Week High, Plans on Buying a UK Technology Company

Codan shares have seen an upswing as much as 3.3% to A$7.76, marking their highest point since the 21st of July.

This Australian technological company recently announced its plan to acquire a UK-based command and control solutions business, Eagle NewCo.

This acquisition, planned at a price of A$22 million ($14.50 million), aims to broaden its Zetron Communications into the UK, Europe, and Middle East.

Eagle is expected to marginally contribute to Codan’s profits for the financial year 2024.

The expectation for the Eagle business is to be EPS-accretive in its second year of ownership.

Codan’s stock has shown a significant increase of 83.2% this year, compared to a 6.12% rise in the ASX All Ordinaries index as of the last closing on July 31.

The shares of Codan were paused on Tuesday whilst awaiting final regulatory approval in the UK regarding the proposed agreement.

Codan operates in the tech sector, offering a diverse set of products and solutions ranging from tactical communication systems to mining technologies.



<WIRE> PYC Therapeutics Jumps After U.S. FDA Fast-Track Nod for Eye Disease Drug (ASX:PYC)

Shares of PYC Therapeutics rise as much as 15.5% to A$0.067, reaching their highest level since July 18.

Australia-based clinical biotech company announces that its VP-001 program received U.S.

FDA fast-track designation.

VP-001 is a potential treatment for Retinitis Pigmentosa type 11 (RP11), a blinding eye disease that begins in childhood.

The company adds that the drug candidate is now eligible for accelerated approval and priority review.

PYC Therapeutics' stock has fallen 15.9% YTD, versus a 6.1% increase in the ASX All Ordinaries index.


<WIRE> Incitec Pivot hits 2-1/2-month high on Australia fertiliser business sale report (ASX:IPL)

Top fertiliser maker Incitec Pivot has tapped Indonesia’s Pupuk Kaltim as preferred buyer of its big Australian fertilizer business, according to Australian Financial Review.

The unit is expected to be worth about A$1.5 bln.

Incitec and Pupuk Kaltim did not immediately respond to requests for comments.

More than 5 mln shares change hands, compared with the 30-day average volume of 7.9 mln shares.

Five of 11 analysts rate the stock “buy” or higher and six “hold”; their median PT is A$3.32 – Refinitiv data.

The stock had fallen 19.4% this year, as of last close.

Incitec Pivot is a top fertiliser maker based in Australia.